Related Experiment Video

Updated: Jun 2, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling

Bekir Cinar1, Filiz Kisaayak Collak, Delia Lopez

  • 1Department of Medicine-Hematology/Oncology and Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, University of California, Los Angeles, California 90048, USA. bekir.cinar@cshs.org

Cancer Research
|April 23, 2011
PubMed

Insights

The serine-threonine kinase MST1 interacts with the androgen receptor (AR) to inhibit its activity, suppressing prostate cancer cell growth. This discovery highlights MST1 as a potential therapeutic target for prostate cancer.

Area of Science:

  • Molecular oncology
  • Cell signaling
  • Cancer biology

Background:

  • The MST1 serine-threonine kinase is part of a tumor suppressor network and is implicated in cancer.
  • The specific role of MST1 in prostate cancer (PCa) remains unclear.
  • Understanding MST1's function in PCa is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate a potential biochemical and functional link between androgen receptor (AR) and MST1 signaling in prostate cancer.
  • To elucidate the mechanism by which MST1 affects AR activity and prostate cancer cell growth.

Main Methods:

  • Coimmunoprecipitation (co-IP) assays to detect protein complex formation.
  • Promoter reporter assays to assess AR transcriptional activity.
  • Molecular genetic methods, in vitro kinase assays, and site-specific mutagenesis.
  • Analysis of AR-chromatin binding and prostate cancer cell growth in vitro and in vivo.

Main Results:

  • MST1 forms a protein complex with AR and antagonizes AR transcriptional activity.
  • MST1 acts as a potent AR kinase, but its kinase activity and proapoptotic functions are not required for AR inhibition.
  • MST1 localizes to AR-chromatin complexes and reduces AR binding to androgen-responsive promoters, suppressing prostate cancer cell and tumor growth.

Conclusions:

  • MST1 directly interacts with and inhibits AR signaling in prostate cancer.
  • MST1 suppresses prostate cancer cell proliferation and tumor growth, independent of its kinase activity.
  • MST1 represents a novel therapeutic target, linking androgenic and growth factor signaling pathways in prostate cancer.

More Related Videos

TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing07:05

TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing

Published on: February 26, 2021

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells08:11

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Published on: August 7, 2021

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...